메뉴 건너뛰기
Nature Clinical Practice Oncology
Volumn 5, Issue 6, 2008, Pages 312-313
Comparison of gemcitabine plus platinum analog with gemcitabine alone in advanced pancreatic cancer: Commentary
Author keywords

[No Author keywords available]
Indexed keywords

BEVACIZUMAB; CETUXIMAB; CISPLATIN; ERLOTINIB; FLUOROPYRIMIDINE; GEMCITABINE; OXALIPLATIN; PLATINUM COMPLEX;
EID: 44649094193     PISSN: 17434254     EISSN: 17434262     Source Type: Journal    
DOI: 10.1038/ncponc1128     Document Type: Short Survey
Times cited : (2)
References (5)
  • 1
    • 34249933404 scopus 로고    scopus 로고
    • Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group
    • Moore MJ et al. (2007) Erlotinib plus gemcitabine compared with gemcitabine alone in patients with advanced pancreatic cancer: A phase III trial of the National Cancer Institute of Canada Clinical Trials Group. J Clin Oncol 25: 1960-1966
    • (2007) J Clin Oncol , vol.25 , pp. 1960-1966
    • Moore, M.J.1
  • 2
    • 34247188535 scopus 로고    scopus 로고
    • Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer
    • Sultana A et al. (2007) Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. J Clin Oncol 25: 2607-2615
    • (2007) J Clin Oncol , vol.25 , pp. 2607-2615
    • Sultana, A.1
  • 3
    • 33746147692 scopus 로고    scopus 로고
    • Phase III trial of gemcitabine (30-minute infusion) versus gemcitabine (fixed-doserate infusion [FDR]) versus gemcitabine plus oxaliplatin (GEMOX) in patients with advanced pancreatic cancer (E6201) [summary]
    • Poplin E et al. (2006) Phase III trial of gemcitabine (30-minute infusion) versus gemcitabine (fixed-doserate infusion [FDR]) versus gemcitabine plus oxaliplatin (GEMOX) in patients with advanced pancreatic cancer (E6201) [summary]. Clin Oncol 24: S180
    • (2006) Clin Oncol , vol.24
    • Poplin, E.1
  • 4
    • 35548941394 scopus 로고    scopus 로고
    • A double-blind, placebo-controlled, randomized phase III trial of gemcitabine (G) plus bevacizumab (B) versus gemcitabine plus placebo in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis of Cancer and Leukemia Group B (CALGB) [abstract]
    • Kindler HL et al. (2007) A double-blind, placebo-controlled, randomized phase III trial of gemcitabine (G) plus bevacizumab (B) versus gemcitabine plus placebo in patients (pts) with advanced pancreatic cancer (PC): A preliminary analysis of Cancer and Leukemia Group B (CALGB) [abstract]. J Clin Oncol 25
    • (2007) J Clin Oncol , vol.25
    • Kindler, H.L.1
  • 5
    • 36549083856 scopus 로고    scopus 로고
    • Phase III study of gemcitabine (G) plus cetuximab (C) versus gemcitabine in patients (pts) with locally advanced or metastatic pancreatic adenocarcinoma (PC): SWOG S0205 study [abstract]
    • Philip PA et al. (2007) Phase III study of gemcitabine (G) plus cetuximab (C) versus gemcitabine in patients (pts) with locally advanced or metastatic pancreatic adenocarcinoma (PC): SWOG S0205 study [abstract]. J Clin Oncol 25
    • (2007) J Clin Oncol , vol.25
    • Philip, P.A.1

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.